Results 81 to 90 of about 2,259,874 (301)

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Pediatric Functional Constipation Gastrointestinal Symptom Profile Compared With Healthy Controls

open access: yes, 2015
Patient-reported outcomes are necessary to evaluate the gastrointestinal symptom profile of patients with functional constipation. Study objectives were to compare the gastrointestinal symptom profile of pediatric patients with functional constipation ...
Pediatric Quality of Life Inventory Gastrointestinal Symptoms Module Testing Study Consortium   +8 more
core   +1 more source

SARS-CoV-2 Variant-Specific Gastrointestinal Symptoms of COVID-19: 2023 Update

open access: yes, 2023
The gastrointestinal (GI) tract may be a significant entrance or interaction site for SARS-CoV-2; therefore, the gut mucosal immune system participates in virus interaction as a first-line physical and immunological defense, leading to GI involvement and
Snezhina Lazova   +25 more
core   +1 more source

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis

open access: yesArthritis Care &Research, EarlyView.
Objective This study aims to identify factors associated with patient global assessment (PtGA) and physician global assessment (PhGA) and discordance between them in systemic sclerosis (SSc). Methods Data from adults with early SSc (<5 years) from the Collaborative National Quality and Efficacy Registry were included.
Ellen Romich   +35 more
wiley   +1 more source

Antidepressants and gastrointestinal symptoms in the general Dutch adult population

open access: yes, 2014
Contains fulltext : 136013.pdf (Publisher’s version ) (Closed access)BACKGROUND: Gastrointestinal symptoms are frequently reported adverse effects of antidepressants, but antidepressants are also a treatment modality in functional ...
Eikendal, T.   +8 more
core   +1 more source

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

open access: yesArthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa   +3 more
wiley   +1 more source

Clinical changes in the gastrointestinal system as a result of the influence of Covid-19 [PDF]

open access: yesBIO Web of Conferences
Research shows that, in addition to primarily presenting as a lung infection, coronavirus infections have been re-established to have significant extrapulmonary complications that affect multiple organ systems, including the gastrointestinal tract ...
Nurbayev Farmon
doaj   +1 more source

Dietary fibre in the management of gastrointestinal symptoms

open access: yes, 2012
Dietary fibre in the management of gastrointestinal ...
Smith, Graeme D, Graeme D Smith
core   +1 more source

Gastrointestinal symptoms in abused nonpatient women

open access: yesBMC Women's Health
Background Severely abused nonpatient women report a high number of gastrointestinal (GI) symptoms and GI syndromes. Little is known about whether the abuse‒symptom relationship varies across different life, social, and community conditions. Objective To
Nadia Pallotta   +6 more
doaj   +1 more source

The Gut–Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort

open access: yesArthritis Care &Research, EarlyView.
Objective Cardiac involvement significantly impacts prognosis in systemic sclerosis (SSc), highlighting the need for early risk stratification. Gastrointestinal (GI) symptoms are common and often manifest early. Emerging data suggest a link between GI and cardiac manifestations, possibly through shared mechanisms like dysautonomia.
Francesca R. Di Ciommo   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy